Real World Evidence & Research

In this episode of Unscripted, the AMCP Podcast, we welcome Casey Koch, PharmD, Clinical Pharmacy Coordinator at Select Health. Join us as we explore the evolving landscape of inflammatory bowel disease (IBD), including the latest treatment advancements, guideline updates, and the role of managed care pharmacy in optimizing patient outcomes. From biologics to biosimilars, personalized medicine, and health disparities, we dive deep into the complexities of IBD management and what the future holds for patients and providers alike.

In this webinar, you'll explore the impact of RSV on U.S. infants, examine key clinical studies on nirsevimab, and review global real-world data on its effectiveness. You'll also learn how to implement immunization strategies to reduce RSV lower respiratory tract infections (LRTI), with practical takeaways for improving coverage and reimbursement decisions.

AMCP supports the use of value frameworks as a resource for determining the value of pharmaceuticals and other health technologies when the Frameworks are based on sound methods using good scientific evidence and economic models.